Genomic structure and genetic mapping of the human neutral cysteine protease bleomycin hydrolase.

Abstract

Bleomycin hydrolase (BH) is the only known eukaryotic enzyme that inactivates the widely used antineoplastic agent bleomycin (BLM) and is a primary candidate gene for protection against lethal BLM-induced pulmonary fibrosis and for BLM resistance in tumors. Human BH was found to exist as a single gene that was mapped to chromosome 17 using National Institute of General Medical Sciences human/rodent hybrid mapping panels and localized to 17q11.1-11.2 by linkage analysis using the Centre d'Etude du Polymorphisme Humain reference database. The human BH gene consisted of 11 exons ranging in size from 69-198 bp separated by introns of approximately 1 kb, reflecting the archetypal genomic structure of the cysteine protease family. A polymorphic site was identified in the eleventh exon at bp 1450 encoding either valine or isoleucine. These findings provide essential tools required to define the role of BH in BLM-induced pulmonary fibrosis and BLM resistance in tumors.

• Authors: S E Montoya, R E Ferrell, J S Lazo
• Journal: Cancer research (Cancer Res) Vol. 57 Issue 19 Pg. 4191-5 (Oct 01 1997) ISSN: 0008-5472 [Print] United States
• PMID: 9331073 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Bleomycin
• Cysteine Endopeptidases
• bleomycin hydrolase

Topics

• Animals
• Base Sequence
• Bleomycin (adverse effects)
• Chromosome Mapping
• Chromosomes, Human, Pair 17 (genetics)
• Cysteine Endopeptidases (genetics)
• Disease Susceptibility
• Drug Resistance, Neoplasm
• Exons (genetics)
• Genes
• Humans
• Hybrid Cells
• Molecular Sequence Data
• Polymorphism, Genetic
• Pulmonary Fibrosis (chemically induced, genetics)